User profiles for Haydn Kissick

Haydn Kissick

Emory University
Verified email at emory.edu
Cited by 7898

CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions

…, AO Kamphorst, SJ Im, HT Kissick… - Annual review of …, 2018 - annualreviews.org
Antigen-specific CD8 T cells are central to the control of chronic infections and cancer, but
persistent antigen stimulation results in T cell exhaustion. Exhausted CD8 T cells have …

An intra-tumoral niche maintains and differentiates stem-like CD8 T cells

…, SJ Im, AO Kamphorst, A Reyes, Y Liu, H Kissick - Nature, 2019 - nature.com
Tumour-infiltrating lymphocytes are associated with a survival benefit in several tumour
types and with the response to immunotherapy 1 , 2 , 3 , 4 , 5 , 6 , 7 – 8 . However, the reason …

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

SJ Im, M Hashimoto, MY Gerner, J Lee, HT Kissick… - Nature, 2016 - nature.com
Chronic viral infections are characterized by a state of CD8 + T-cell dysfunction that is associated
with expression of the programmed cell death 1 (PD-1) inhibitory receptor 1 , 2 , 3 , 4 . …

Origin and differentiation of human memory CD8 T cells after vaccination

RS Akondy, M Fitch, S Edupuganti, S Yang, HT Kissick… - Nature, 2017 - nature.com
The differentiation of human memory CD8 T cells is not well understood. Here we address
this issue using the live yellow fever virus (YFV) vaccine, which induces long-term immunity in …

Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer

CS Eberhardt, HT Kissick, MR Patel, MA Cardenas… - Nature, 2021 - nature.com
T cells are important in tumour immunity but a better understanding is needed of the
differentiation of antigen-specific T cells in human cancer 1 , 2 . Here we studied CD8 T cells in …

CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor

…, C Cimmino, C Larsen, V Master, M Sanda, H Kissick - Immunity, 2023 - cell.com
Improvements in tumor immunotherapies depend on better understanding of the anti-tumor
T cell response. By studying human tumor-draining lymph nodes (TDLNs), we found that …

PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program

…, K Araki, MA Cardenas, P Li, RR Jadhav, HT Kissick… - Nature, 2022 - nature.com
Combination therapy with PD-1 blockade and IL-2 is highly effective during chronic lymphocytic
choriomeningitis virus infection 1 . Here we examine the underlying basis for this synergy…

Effector CD8 T cells dedifferentiate into long-lived memory cells

B Youngblood, JS Hale, HT Kissick, E Ahn, X Xu… - Nature, 2017 - nature.com
Memory CD8 T cells that circulate in the blood and are present in lymphoid organs are an
essential component of long-lived T cell immunity. These memory CD8 T cells remain poised …

[HTML][HTML] PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells

…, S Wullschleger, M Tichet, D Hanahan, HT Kissick… - Nature, 2022 - nature.com
Expansion and differentiation of antigen-experienced PD-1 + TCF-1 + stem-like CD8 + T cells
into effector cells is critical for the success of immunotherapies based on PD-1 blockade 1 , …

[PDF][PDF] Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1+ stem-like CD8+ T cells during chronic infection

…, SJ Im, GJ Freeman, WJ Leonard, HT Kissick… - Immunity, 2019 - cell.com
T cell dysfunction is a characteristic feature of chronic viral infection and cancer. Recent studies
in chronic lymphocytic choriomeningitis virus (LCMV) infection have defined a PD-1 + Tcf…